Grifols Gross Profit 2012-2019 | GRFS

Grifols annual/quarterly gross profit history and growth rate from 2012 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Grifols gross profit for the quarter ending March 31, 2019 was $0.000B, a 100% decline year-over-year.
  • Grifols gross profit for the twelve months ending March 31, 2019 was $1.812B, a 14.37% decline year-over-year.
  • Grifols annual gross profit for 2018 was $2.421B, a 0.49% decline from 2017.
  • Grifols annual gross profit for 2017 was $2.432B, a 14.95% increase from 2016.
  • Grifols annual gross profit for 2016 was $2.116B, a 1.31% decline from 2015.
Grifols Annual Gross Profit
(Millions of US $)
2018 $2,421
2017 $2,432
2016 $2,116
2015 $2,144
2014 $2,259
2013 $1,883
2012 $1,710
2011 $1,900
Grifols Quarterly Gross Profit
(Millions of US $)
Q1 2019 $0
Q2 2018 $617
Q2 2017 $617
Q1 2017 $578
Q4 2016 $543
Q3 2016 $522
Q2 2016 $528
Q1 2016 $523
Q4 2015 $572
Q3 2015 $537
Q2 2015 $526
Q1 2015 $506
Q4 2014 $442
Q3 2014 $567
Q2 2014 $532
Q1 2014 $594
Q4 2013 $456
Q3 2013 $471
Q2 2013 $485
Q1 2013 $462
Q4 2012 $421
Q3 2012 $418
Q2 2012 $430
Q1 2012 $423
Q4 2011 $796
Q3 2011 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.779B $5.299B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.313B 34.70
Takeda Pharmaceutical (TAK) Japan $27.201B 7.99
Sage Therapeutics (SAGE) United States $9.044B 0.00
Ionis Pharmaceuticals (IONS) United States $8.958B 19.58
Neurocrine Biosciences (NBIX) United States $7.714B 0.00
Catalent (CTLT) United States $7.679B 30.82
Jazz Pharmaceuticals (JAZZ) Ireland $7.437B 10.19
Nektar Therapeutics (NKTR) United States $5.907B 9.63
Tilray (TLRY) Canada $4.670B 0.00
FibroGen (FGEN) United States $3.751B 0.00
United Therapeutics (UTHR) United States $3.332B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.309B 11.61
Arrowhead Pharmaceuticals (ARWR) United States $2.607B 392.86
PTC Therapeutics (PTCT) United States $2.470B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.924B 6.92
Xencor (XNCR) United States $1.909B 52.11
Portola Pharmaceuticals (PTLA) United States $1.796B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.781B 86.24
Zogenix (ZGNX) United States $1.730B 0.00
Tricida (TCDA) United States $1.720B 0.00
USANA Health Sciences (USNA) United States $1.688B 14.67
Enanta Pharmaceuticals (ENTA) United States $1.630B 22.28
Ironwood Pharmaceuticals (IRWD) United States $1.590B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.557B 0.00
Heron Therapeutics (HRTX) United States $1.406B 0.00
Aerie Pharmaceuticals (AERI) United States $1.387B 0.00
Turning Point Therapeutics (TPTX) United States $1.322B 0.00
Esperion Therapeutics (ESPR) United States $1.309B 0.00
Corcept Therapeutics (CORT) United States $1.190B 16.98
ArQule (ARQL) United States $1.094B 0.00
Radius Health (RDUS) United States $1.078B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.916B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.899B 0.00
Endo (ENDP) Ireland $0.812B 1.31
Aptorum Group (APM) China $0.755B 0.00
Odonate Therapeutics (ODT) United States $0.751B 0.00
CannTrust Holdings (CTST) Canada $0.706B 0.00
Organogenesis Holdings (ORGO) United States $0.658B 0.00
Translate Bio (TBIO) United States $0.638B 0.00
TherapeuticsMD (TXMD) United States $0.603B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.573B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.567B 0.00
Dermira (DERM) United States $0.510B 0.00
Akebia Therapeutics (AKBA) United States $0.502B 0.00
ChemoCentryx (CCXI) United States $0.495B 0.00
GlycoMimetics (GLYC) United States $0.485B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Siga Technologies (SIGA) United States $0.450B 1.06
BioSpecifics Technologies Corp (BSTC) United States $0.420B 21.18
Flexion Therapeutics (FLXN) United States $0.414B 0.00
Collegium Pharmaceutical (COLL) United States $0.414B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.400B 0.00
Karyopharm Therapeutics (KPTI) United States $0.386B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.371B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.370B 0.00
KalVista Pharmaceuticals (KALV) United States $0.367B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.349B 0.00
TCR2 Therapeutics (TCRR) United States $0.349B 0.00
Rafael Holdings (RFL) United States $0.334B 0.00
Forty Seven (FTSV) United States $0.333B 0.00
Harpoon Therapeutics (HARP) United States $0.309B 0.00
Molecular Templates (MTEM) United States $0.299B 0.00
OptiNose (OPTN) United States $0.298B 0.00
Xeris Pharmaceuticals (XERS) United States $0.291B 0.00
CASI Pharmaceuticals (CASI) United States $0.290B 0.00
ImmunoGen (IMGN) United States $0.280B 0.00
Concert Pharmaceuticals (CNCE) United States $0.271B 0.00
Dova Pharmaceuticals (DOVA) United States $0.264B 0.00
Aratana Therapeutics (PETX) United States $0.246B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.238B 0.00
Minerva Neurosciences (NERV) United States $0.231B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.225B 0.00
Lannett Co Inc (LCI) United States $0.222B 2.15
Recro Pharma (REPH) United States $0.215B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.200B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.196B 0.00
Aldeyra Therapeutics (ALDX) United States $0.195B 0.00
Opexa Therapeutics (ACER) United States $0.194B 0.00
Bio Blast Pharma (ENLV) Israel $0.188B 0.00
Galectin Therapeutics (GALT) United States $0.187B 0.00
Ocular Therapeutix (OCUL) United States $0.187B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
MEI Pharma (MEIP) United States $0.183B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.182B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.169B 0.00
Nature's Sunshine Products (NATR) United States $0.160B 51.88
Ardelyx (ARDX) United States $0.159B 0.00
Calithera Biosciences (CALA) United States $0.152B 0.00
Redhill Biopharma (RDHL) Israel $0.150B 0.00
IMV INC (IMV) Canada $0.148B 0.00
AgeX Therapeutics (AGE) United States $0.148B 0.00
Jounce Therapeutics (JNCE) United States $0.147B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Majesco Entertainment (PTE) United States $0.138B 0.00
Neon Therapeutics (NTGN) United States $0.131B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Tyme Technologies (TYME) United States $0.114B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.103B 0.00
DURECT (DRRX) United States $0.102B 0.00
Aquestive Therapeutics (AQST) United States $0.101B 0.00
Avenue Therapeutics (ATXI) United States $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.098B 70.00
Bellicum Pharmaceuticals (BLCM) United States $0.097B 0.00
China SXT Pharmaceuticals (SXTC) China $0.096B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Champions Oncology (CSBR) United States $0.094B 0.00
Infinity Pharmaceuticals (INFI) United States $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.092B 0.00
Cardiome Pharma (CORV) Canada $0.092B 0.00
MediWound (MDWD) Israel $0.088B 0.00
Natural Alternatives (NAII) United States $0.088B 8.80
Nivalis Therapeutics (ALPN) United States $0.084B 0.00
India Globalization Capital (IGC) United States $0.081B 0.00
Capnia (SLNO) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Adherex Technologies (FENC) United States $0.078B 0.00
Novan (NOVN) United States $0.072B 0.00
Melinta Therapeutics (MLNT) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.060B 0.00
Neos Therapeutics (NEOS) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Genocea Biosciences (GNCA) United States $0.051B 0.00
Zafgen (ZFGN) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.046B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.045B 0.00
KemPharm (KMPH) United States $0.044B 0.00
Lipocine (LPCN) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
ContraFect (CFRX) United States $0.039B 0.00
Bio-Path Holdings (BPTH) United States $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.033B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.032B 0.00
PharmAthene (ALT) United States $0.030B 0.00
IsoRay (ISR) United States $0.028B 0.00
Heat Biologics (HTBX) United States $0.025B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.025B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
GTx (ONCT) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Pain Therapeutics (SAVA) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.64
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 0.00
Achieve Life Sciences (ACHV) United States $0.014B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.013B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.81
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.007B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00